Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The antimetastatic effects of calorie restriction are negated by voluntary exercise in an aggressive breast cancer mouse model.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Harnessing Neoantigen-specific T Cells for Precision Immunotherapy in Hematologic Malignancies.

Blood·2026

Same author

Vaccine-derived T-cell responses are insufficient to generate protective immunity to SARS-CoV-2.

Scientific reports·2026

Same author

Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026

Same author

Immunometabolic resistors of aging in long-lived golden spiny mice.

Science advances·2026

Same author

Predictive markers for the efficacy of CAR T-cell therapy: the interplay between CAR T-cell fitness and systemic immunity.

Blood advances·2025

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Models for lymphoma.

Arya Biragyn¹, Larry W Kwak¹

¹National Cancer Institute, Frederick, Maryland.

Current Protocols in Immunology

|April 25, 2008

Summary

This study details methods for creating advanced recombinant vaccines against lymphoma. Researchers developed novel fusion proteins and DNA-based vaccines to enhance anti-tumor immune responses.

Area of Science:

Oncology
Immunology
Biotechnology

Background:

Development of effective therapeutic vaccines for lymphoma remains a critical challenge.
Second-generation recombinant vaccines offer promising avenues for cancer immunotherapy.
Current methods require refinement for improved immunogenicity and efficacy.

Purpose of the Study:

To describe experimental procedures for developing novel lymphoma vaccine formulations.
To present methods for enhancing the immunogenicity of tumor-derived antigens.
To provide protocols for both protein- and DNA-based vaccine strategies.

Main Methods:

In vitro culture and in vivo challenge of lymphoma cell lines in syngeneic mice.
Production of idiotype (Id)-based and cellular lymphoma vaccine formulations.

More Related Videos

Using Optical Tweezers for the Generation of Hybrid Spheroids

Using Optical Tweezers for the Generation of Hybrid Spheroids

Published on: May 30, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Related Experiment Videos

Last Updated: Jul 5, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Using Optical Tweezers for the Generation of Hybrid Spheroids

Using Optical Tweezers for the Generation of Hybrid Spheroids

Published on: May 30, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Engineering of chemokine-fusion proteins for enhanced immunogenicity.

Cloning and expression of cytokine genes (e.g., murine GM-CSF) in lymphoma cells.

Chemical conjugation of immunoglobulin (Ig) protein with KLH for vaccine development.

Application of the Helios Gene Gun System for DNA tumor vaccine immunization.

Main Results:

Successful development of novel vaccine strategies targeting lymphoma.
Demonstration of methods to render nonimmunogenic tumor antigens immunogenic.
Establishment of protocols for producing recombinant protein and DNA-based vaccines.
Successful immunization of mice using diverse vaccine formulations.

Conclusions:

The described experimental procedures provide a robust framework for developing second-generation recombinant lymphoma vaccines.
Novel approaches, including chemokine fusion proteins and cytokine gene delivery, show potential for enhancing anti-tumor immunity.
These methods offer versatile tools for advancing cancer vaccine research and therapeutic development.